Biological and clinical features of non-Hodgkin's lymphoma in the elderly

Journal of B.U.ON.

Volumn 17, Issue 4, 2012, Pages 753-760

  Hajder, Jelena ^a   Marisavljevic, D ^a,b   Stanisavljevic, N ^a   Mihaljevic, B ^b,c   Kovcin, V ^a   Markovic, O ^a   Zivkovic, R ^a  

^a Medical Center Bezanijska Kosa   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Clinicopathological features; Elderly patients; Non Hodgkin lymphoma; Prognosis; Response to therapy; Survival

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; LACTATE DEHYDROGENASE;

ADULT; ADVERSE OUTCOME; AGE; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART DISEASE; HEPATORENAL SYNDROME; HISTOLOGY; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; KARNOFSKY PERFORMANCE STATUS; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYMPTOM; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84872368733     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E et al. Cancer Statistics 2008. CA Cancer J Clin 2008; 58: 71-96.
2. www/seer.cancer.gov/statfacts/html/nhl.html
3. Coiffier B. Non-Hodgkin's lymphomas in elderly patients. In: Canellos G, Lister T (Eds): The lymphomas. Philadelphia: W.B. Saunders Co, 1998.
4. Thieblemont C, Coiffier B. Lymphoma in Older Patients. J Clin Oncol 2007; 25: 1916-1923. (Pubitemid 46854426)
5. D'Amore F, Brincker H, Christensen BE et al. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. Ann Oncol 1992; 3: 379-386.
6. Carbone A, Tirelli U, Volpe R et al. Non-Hodgkin's lymphoma in the elderly. Cancer 1986; 57: 2185-2189.
7. Carbone A, Volpe R, Gloghini A et al. Non-Hodgkin's lymphoma in the elderly. Cancer 1990; 66: 1991-1994.
8. Ballester OF, Moscinski L, Spiers A et al. L. Non-Hodgkin's lymphoma in the older person: a review. J Am Geriatr Soc 1993; 41: 1245-1254. (Pubitemid 23324876)
9. Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61: 1023-1027.
10. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392. (Pubitemid 24273002)
11. Robb-Smith AH. U.S. National Cancer Institute Working formulation of non-Hodgkin's lymphomas for clinical use. Lancet 1982; 32: 432-434.
12. Sorror ML, Maris MB, Storb R et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Transplantation 2005; 106: 2912-2919. (Pubitemid 41510773)
13. Cheson BD, Horning SJ, Coiffier B et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. J Clin Oncol 1999; 17: 1244-1253. (Pubitemid 29162950)
14. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135.
15. Maartense E, Hermans J, Kluin-Nelemans C et al. Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands. Ann Oncol 1998; 9: 1219-1227. (Pubitemid 28552812)
16. Fratino L, Bernardi D. European experiences on aggressive non-Hodkgin's lymphoma in elderly patients. Crit Rev Oncol/ Hematol 2004; 51: 229-240.
17. Varoczy L, Alpar D, Zsofia S et al. Malignant lymphoma in the elderly: A single institute experience highlights future directions. Arch Gerontol Geriatr 2007; 45: 43-53. (Pubitemid 46654259)
18. Thieblemont C, Grossoeuvre A, Houot R et al. Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 2008; 19: 774-779. (Pubitemid 351461051)
19. Maartense E, Kluin-Nelmans HC, Le Cessie S et al. Different age limits for elderly with indolent and aggressive non-Hodgkin lymphoma and role of relative survival with increasing age. Analysis of population based non-Hodgkin lymphoma registry. Cancer 2000; 89: 2667-2676.
20. Hoerni B, Sotto J, Eghbali H et al. Non-Hodgkin's malignant lymphomas in patients older than 80: Seventy cases. Cancer 1988; 61: 2057-2059.
21. Bai L, Yang M, Chiou T. Non-Hodgkin lymphoma in the elderly patients. Cancer 2003; 98: 1188-1195.
22. Goss PE. Non-Hodgkin's lymphomas in elderly patients. Leuk Lymphoma 1993; 10: 147-156. (Pubitemid 23256586)
23. Van Spronsen DJ, Janssen-Heijnen MLG, Breed WP et al. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996. Ann Hematol 1999; 78: 315-319. (Pubitemid 29364041)
24. Spronsen D, Janssen-Heijnen MLG, Lemmens VEPP et al. Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry. Eur J Cancer 2005; 41: 1051-1057. (Pubitemid 40602858)
25. Cronin-Fentoin D, Sharp L, Deady S. Treatment and survival for NHL: Influence of histological subtype, age and other factors in a population-based study (1999-2001). Eur J Cancer 2006; 42: 2786-2793. (Pubitemid 44584661)
26. The Non-Hodgkin's Lymphoma Classification Project. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. Ann Oncol 1997; 8: 973-978.
27. Solal-Celigny P, Chastang C, Herrera A et al. Age as the main prognostic factor in adult aggressive non-Hodgkin lymphoma. Am J Med 1987; 83: 1075-1079. (Pubitemid 18098880)